TUDOR INVESTMENT CORP ET AL

Position in RCUS — Arcus Biosciences, Inc.

CIK 923093 STAMFORD, CT

Position in RCUS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,672,317

-$299,550 QoQ

Shares Held

216,311

+3.7% QoQ

Ownership

0.172%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 50.ToString("F0")% Shared 50.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $331,771,687 across 116 Biotechnology names. RCUS ranks #15 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc.	462,588	$53,114,354
2	RPRX	Royalty Pharma plc	671,680	$32,220,489
3	XENE	Xenon Pharmaceuticals Inc.	495,591	$28,818,616
4	APLS	Apellis Pharmaceuticals, Inc.	650,000	$26,149,500
5	TERN	Terns Pharmaceuticals, Inc.	267,520	$14,103,654
6	FOLD	AMICUS THERAPEUTICS, INC.	900,000	$13,014,000
7	ABVX	Abivax S.A.	101,611	$11,314,384
8	RVMD	Revolution Medicines, Inc.	87,852	$8,543,607

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,672,317	216,311	+3.7%	Shares	Defined	2026-05-15
2025-12-31	$4,971,867	208,639	+290.2%	Shares	Defined	2026-02-17
2025-03-31	$419,708	53,466	+24.4%	Shares	Defined	2025-05-15
2024-12-31	$639,793	42,968	-5.9%	Shares	Defined	2025-02-14
2024-09-30	$697,988	45,650	+62.0%	Shares	Defined	2024-11-14
2023-09-30	$505,705	28,173	-31.6%	Shares	Defined	2023-11-15
2021-09-30	$1,436,644	41,200	-23.8%	Shares	Defined	2021-11-17
2021-06-30	$1,484,405	54,057	+644.5%	Shares	Defined	2021-08-16
2021-03-31	$203,888	7,261	-79.6%	Shares	Defined	2021-05-17
2020-12-31	$923,059	35,557	-46.6%	Shares	Defined	2021-02-16
2020-06-30	$1,645,927	66,529	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.